Articles from Instrument Business Outlook (September 30, 2008)

Title	Author	Type	Words
All four IBO indexes follow market's decline.			3678
Biotechnology.		Brief article	117
Clinical.		Brief article	112
Energy.			122
Fluidigm withdraws IPO.			166
Food.			123
GE buys microcalorimetry firm.		Brief article	179
GE sells remainder of microarray business.			106
India.			133
Invitrogen announces post-merger structure.			392
Market profile: GC-MS in food analysis.		Statistical table	947
New R&D laboratories.			1561
Sequenom buys clinical diagnostic lab.		Brief article	212
South Africa.		Brief article	190
Sweden.		Brief article	86
XRD flourishes in a broad market.			1435